TScan Therapeutics (TCRX) Assets (2020 - 2026)
TScan Therapeutics (TCRX) reported Assets of $171.45 million for Q2 2026, down 42.6% from $298.56 million a year earlier and down 15.1% from the prior quarter.
Powered by 
Analysis
TScan Therapeutics (TCRX) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, TScan Therapeutics posted Assets of $228.79 million, down 38.4% from FY2024.
- Assets has a five-year compound annual growth rate of 35.7% (FY2020 to FY2025).
- By year, Assets came in at $371.12 million in FY2024 (+36.4%), $272.15 million in FY2023 (+36.7%), $199.09 million in FY2022 (+5.8%) and $188.11 million in FY2021 (+278.2%).
- The Q2 2026 figure ranks as the lowest quarterly Assets since Q3 2022.
- Year over year, Assets has now declined in each of the last five quarters, with an average decline of 8.9% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q4 2021 (growth of 278.2%); the low point was Q2 2026 (a decline of 42.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $201.99 million (Q1 2026), $228.79 million (Q4 2025) and $262.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | TScan Therapeutics | 40.28 Mn | 40.28 Mn | - | 171.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 171.45 Mn |
| Mar 31, 2026 | 201.99 Mn |
| Dec 31, 2025 | 228.79 Mn |
| Sep 30, 2025 | 262.23 Mn |
| Jun 30, 2025 | 298.56 Mn |
| Mar 31, 2025 | 332.71 Mn |
| Dec 31, 2024 | 371.12 Mn |
| Sep 30, 2024 | 348.03 Mn |
| Jun 30, 2024 | 374.87 Mn |
| Mar 31, 2024 | 240.83 Mn |
| Dec 31, 2023 | 272.15 Mn |
| Sep 30, 2023 | 291.38 Mn |
| Jun 30, 2023 | 316.92 Mn |
| Mar 31, 2023 | 173.58 Mn |
| Dec 31, 2022 | 199.09 Mn |
| Sep 30, 2022 | 165.45 Mn |
| Jun 30, 2022 | 152.42 Mn |
| Mar 31, 2022 | 168.20 Mn |
| Dec 31, 2021 | 188.11 Mn |
| Sep 30, 2021 | 204.89 Mn |
API Access
TScan Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=TCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();